Literature DB >> 3975327

Pseudocyesis: psychologic and neuroendocrine interrelationships.

M N Starkman, J C Marshall, J La Ferla, R P Kelch.   

Abstract

There is a paucity of information concerning the interrelationship of psychiatric and neuroendocrine abnormalities in pseudocyesis. We have studied two patients using a multimodal investigatory approach, with particular attention to the association of depression and alterations in endocrine secretory patterns. Both patients had abnormal growth hormone secretory patterns, as demonstrated by lack of sleep-associated peaks and the absence of a response to L-dopa administration. Both patients had elevated testosterone and estradiol levels and normal prolactin levels. Only the patient who met DSM III criteria for a major depressive episode had abnormally elevated luteinizing hormone (LH) levels and large LH pulse amplitudes. These findings, together with a review of cases reported in the literature, suggest that no single neuroendocrine profile is common to all patients with pseudocyesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3975327     DOI: 10.1097/00006842-198501000-00005

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  4 in total

Review 1.  Prolactin and human weight disturbances: A puzzling and neglected association.

Authors:  Luis G Sobrinho; Nelson D Horseman
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 2.  Biopsychosocial view to pseudocyesis: A narrative review.

Authors:  Marzieh Azizi; Forouzan Elyasi
Journal:  Int J Reprod Biomed       Date:  2017-09

3.  Psychosocial and cultural aspects of pseudocyesis.

Authors:  Perpetus C Ibekwe; Justin U Achor
Journal:  Indian J Psychiatry       Date:  2008-04       Impact factor: 1.759

Review 4.  Endocrinology and physiology of pseudocyesis.

Authors:  Juan J Tarín; Carlos Hermenegildo; Miguel A García-Pérez; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2013-05-14       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.